4.4 Article Proceedings Paper

Tumor homing indocyanine green encapsulated micelles for near infrared and photoacoustic imaging of tumors

Publisher

WILEY
DOI: 10.1002/jbm.b.33607

Keywords

photoacoustic imaging; indocyanine green; CD44 receptor; hyaluronic acid; near infrared imaging

Funding

  1. Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI12C0810, HI13C2285, HI14C0187]
  2. Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF), Ministry of Education, Science and Technology (MEST) [2011-0030034, NRF-2013R1A2A2A01004668]
  3. Pioneer Research Center Program through the National Research Foundation of Korea, Ministry of Science, ICT & Future Planning [2014M3C1A3053035]
  4. Chonnam National University Hospital Research Institute of Clinical Medicine [CRI14073-3]
  5. Research Program for Green Technologies, National Research Foundation of Korea, Ministry of Science, ICT and Future Planning [2012M3C1A1054502, Brain Korea 21]

Ask authors/readers for more resources

Photoacoustic imaging (PAI) is an emerging analytical modality that is under intense preclinical development for the early diagnosis of various medical conditions, including cancer. However, the lack of specific tumor targeting by various contrast agents used in PAI obstructs its clinical applications. In this study, we developed indocyanine green (ICG)-encapsulated micelles specific for the CD 44 receptor and used in near infrared and photoacoustic imaging of tumors. ICG was hydrophobically modified prior to loading into hyaluronic acid (HA)-based micelles utilized for CD 44 based-targeting. We investigated the physicochemical characteristics of prepared HA only and ICG-encapsulated HA micelles (HA-ICG micelles). After intravenous injection of tumor-bearing mice, the bio-distribution and in vivo photoacoustic images of ICG-encapsulated HA micelles accumulating in tumors were also investigated. Our study further encourages the application of this HA-ICG-based nano-platform as a tumor-specific contrast agent for PAI. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 825-834, 2016.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available